NIH-funded research NIH-funded research

Regulating fat signaling lipids to boost aging muscle health

Official title: Regulation of eicosanoid signaling lipids to improve skeletal muscle function and increase healthspan during aging

Funded at Stanford University · NIH-11582565 · Data updated 2026-11-12

This grant explores how fat-derived signaling molecules control muscle growth and health as we age, with the aim of helping people maintain strength and mobility.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionStanford University
NIH-funded
Lab location1 site (Stanford, United States)
Project startSeptember 15, 2020
Project endJuly 31, 2027
Funding year2026
Award (this year)$386,677
NIH project number2R56AG069858-05A1
Project IDNIH-11582565 on NIH RePORTER

Who could benefit from this research

Could help

Adults aging around 60 and older who are at risk for or experiencing sarcopenia and related muscle weakness.

Less likely to help

Individuals without muscle weakness or aging-related muscle loss may not benefit from these interventions.

What this research studies

As we get older, our muscles don’t respond as well to workouts, which can lead to sarcopenia. The project looks at cellular signals in aging muscle and tests ways to adjust these signals so muscles can grow stronger again. Researchers have found that a molecule called PGE2 and an enzyme that breaks it down (a gerozyme) influence muscle aging, and this grant plans to further test these targets to improve muscle function. The work combines lab studies with potential approaches that could become therapies to support muscle health in older adults.

Why it matters

Potential benefit: If successful, the research could lead to therapies that help older adults gain or preserve muscle mass and strength.

How similar studies have gone: Earlier work in animal models suggests manipulating gerozymes and PGE2 pathways can improve muscle strength, supporting potential benefit in humans.

Where this research is happening

  • Stanford University
    Stanford, United States
    Active

Researchers

  • Principal investigator: Blau, Helen M — Stanford University
  • Study coordinator: Blau, Helen M

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.